These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 37868345)

  • 1. Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases.
    Yuan C; He Y; Xie K; Feng L; Gao S; Cai L
    Front Cell Infect Microbiol; 2023; 13():1282431. PubMed ID: 37868345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota manipulation as an epilepsy treatment.
    Iannone LF; Gómez-Eguílaz M; De Caro C
    Neurobiol Dis; 2022 Nov; 174():105897. PubMed ID: 36257595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.
    Person H; Keefer L
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110209. PubMed ID: 33326819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
    Alharthi A; Alhazmi S; Alburae N; Bahieldin A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics.
    Yang H; Liu Y; Cai R; Li Y; Gu B
    Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.
    Radford-Smith DE; Anthony DC
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.
    Tan Q; Orsso CE; Deehan EC; Kung JY; Tun HM; Wine E; Madsen KL; Zwaigenbaum L; Haqq AM
    Autism Res; 2021 Sep; 14(9):1820-1836. PubMed ID: 34173726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-directed therapy in Parkinson's disease.
    Benvenuti L; Di Salvo C; Bellini G; Seguella L; Rettura F; Esposito G; Antonioli L; Ceravolo R; Bernardini N; Pellegrini C; Fornai M
    Front Pharmacol; 2024; 15():1407925. PubMed ID: 38974034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
    Gupta S; Dinesh S; Sharma S
    Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
    Petra AI; Panagiotidou S; Hatziagelaki E; Stewart JM; Conti P; Theoharides TC
    Clin Ther; 2015 May; 37(5):984-95. PubMed ID: 26046241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
    Pap D; Veres-Székely A; Szebeni B; Vannay Á
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.
    Tang H; Chen X; Huang S; Yin G; Wang X; Shen G
    Rev Neurosci; 2023 Oct; 34(7):763-773. PubMed ID: 36757367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-Gut-Brain Axis and Antidepressant Treatment.
    Lachmansingh DA; Lavelle A; Cryan JF; Clarke G
    Curr Top Behav Neurosci; 2024; 66():175-216. PubMed ID: 37962812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gut Microbiota and Autism Spectrum Disorders: An Overview of Correlations and Potential Implications for Therapeutic Interventions].
    Neubauer J; Kaiser A; Hohmann S
    Z Kinder Jugendpsychiatr Psychother; 2024; 52(3):151-165. PubMed ID: 38098430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment.
    Zou X; Zou G; Zou X; Wang K; Chen Z
    PeerJ; 2024; 12():e17061. PubMed ID: 38495755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.